These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 68228)

  • 1. Haemorrhagic complications of heparin therapy.
    Mant MJ; O'Brien BD; Thong KL; Hammond GW; Birtwhistle RV; Grace MG
    Lancet; 1977 May; 1(8022):1133-5. PubMed ID: 68228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of heparin therapy: Controlled prospective trial.
    Salzman EW; Deykin D; Shapiro RM; Rosenberg R
    N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized prospective trial of continuous vs intermittent heparin therapy.
    Glazier RL; Crowell EB
    JAMA; 1976 Sep; 236(12):1365-7. PubMed ID: 989091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy.
    Monreal M; Urrutia A; Marti S; Cuxart A; Roncales J
    Haemostasis; 1997; 27(2):91-8. PubMed ID: 9212357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control and complications of intermittent heparin therapy.
    Norman CS; Provan JL
    Surg Gynecol Obstet; 1977 Sep; 145(3):338-42. PubMed ID: 888052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin-induced hemorrhage in the treatment of venous thromboembolism].
    Monreal M; Casals A; Las Heras G; Roncalés J; Callejas JM; Martorell A; Lisbona C
    Angiologia; 1990; 42(1):11-5. PubMed ID: 2321800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin treatment of deep venous thrombosis in 280 patients: symptoms related to dosage.
    Holm HA; Finnanger B; Hartmann A; Laerum F; Løhren O; Ruud TE; Stray N; Wolland T
    Acta Med Scand; 1984; 215(1):47-53. PubMed ID: 6695563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin therapy: a randomized prospective study.
    Wilson JR; Lampman J
    Am Heart J; 1979 Feb; 97(2):155-8. PubMed ID: 760446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty.
    Della Valle CJ; Jazrawi LM; Idjadi J; Hiebert RN; Stuchin SA; Steiger DJ; Di Cesare PE
    J Bone Joint Surg Am; 2000 Feb; 82(2):207-12. PubMed ID: 10682729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin therapy in venous thromboembolism.
    Wilson JE; Bynum LJ; Parkey RW
    Am J Med; 1981 Apr; 70(4):808-16. PubMed ID: 7211918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.
    Albada J; Nieuwenhuis HK; Sixma JJ
    Circulation; 1989 Oct; 80(4):935-40. PubMed ID: 2551537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further hazards of heparin therapy in vascular surgery.
    Ariyan S; Stansel HC
    Arch Surg; 1976 Feb; 111(2):120-1. PubMed ID: 1252116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Pineo GF; Green D; Trowbridge AA; Elliott CG; Lerner RG; Hall J; Sparling T; Brettell HR
    N Engl J Med; 1992 Apr; 326(15):975-82. PubMed ID: 1545850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
    Fagher B; Lundh B
    Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for bleeding during treatment of acute venous thromboembolism.
    Wester JP; de Valk HW; Nieuwenhuis HK; Brouwer CB; van der Graaf Y; Meuwissen OJ; Hart HC; Sixma JJ; Banga JD
    Thromb Haemost; 1996 Nov; 76(5):682-8. PubMed ID: 8950773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose heparin: an aid to therapy.
    Covey TH; Baue AE
    Surg Annu; 1980; 12():187-204. PubMed ID: 6996168
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of heparin and streptokinase in the treatment of venous thrombosis.
    Porter JM; Seaman AJ; Common HH; Rösch J; Eidemiller LR; Calhoun AD
    Am Surg; 1975 Sep; 41(9):511-19. PubMed ID: 1101755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding.
    Holm HA; Abildgaard U; Kalvenes S
    Thromb Haemost; 1985 Apr; 53(2):278-81. PubMed ID: 4024037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin.
    Hohl MK; Lüscher KP; Tichý J; Stiner M; Fridrich R; Gruber UF; Käser O
    Obstet Gynecol; 1980 Apr; 55(4):497-500. PubMed ID: 6154272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
    N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.